Literature DB >> 26351472

Frequency of Group B Streptococcal Colonization in Pregnant Women Aged 35- 37 Weeks in Clinical Centers of Shahed University, Tehran, Iran.

Shahrzad Hadavand1, Fatemeh Ghafoorimehr1, Leila Rajabi1, Ali Davati2, Nafiseh Zafarghandi1.   

Abstract

BACKGROUND &
OBJECTIVES: One of the important infectious factors in pregnant mothers and newborns is Group B Streptococcus (GBS). There is no perfect report about prevalence of GBS in Iran and in the case of preterm rupture of amniotic membrane or preterm labor all patients are treated by antibiotics without culture so this has led to adverse taking antibiotics and drug resistance. The present study is intended to determine the frequency of colonization of GBS in the pregnant mother (35-37 weeks), referred to medical centers of Shahed University.
METHODS: Overall, 210 pregnant women (35-37 weeks), referred to medical center of Shahed University, Tehran, Iran were selected as sample group and after filling out the questionnaires about demographic data and midwifery status and the related information of post- partum, the rectovaginal culture was done for them.
RESULTS: Among 210 samples, 7 (3.3%) included positive culture in terms of GBS colonization while all these cases were sensitive to penicillin, ampicillin, cephalothin, nitrofurantoin, and all of the samples were resistant against tetracycline and contrimoxazole. There was no relationship among age, job, education, number of pregnancy, blood pressure background, diabetes and preterm childbirth with positive culture. Similarly, because of limited number of positive cases it was not possible to examine the relationship among GBS colonization and infection in mother and newborn.
CONCLUSION: There was a low frequency in GBS colonization in the studied hospitals and the study inside the country also confirms this finding.

Entities:  

Keywords:  Amniotic Membrane; Preterm Labor; Rupture; Streptococcus Group B

Year:  2015        PMID: 26351472      PMCID: PMC4539761     

Source DB:  PubMed          Journal:  Iran J Pathol        ISSN: 1735-5303


  14 in total

1.  Rapid screening for Streptococcus agalactiae in vaginal specimens of pregnant women by fluorescent in situ hybridization.

Authors:  Laura A Artz; Volkhard A J Kempf; Ingo B Autenrieth
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

2.  Prevalence rate of group B streptococcal colonization among women in labor at King Abdul-Aziz University Hospital.

Authors:  Tarik Y Zamzami; Anas M Marzouki; Hassan A Nasrat
Journal:  Arch Gynecol Obstet       Date:  2010-11-16       Impact factor: 2.344

3.  Group B streptococcus infection rate unchanged by gestational diabetes.

Authors:  J M Piper; S Georgiou; E M Xenakis; O Langer
Journal:  Obstet Gynecol       Date:  1999-02       Impact factor: 7.661

4.  Group B streptococci urine isolates and their antimicrobial susceptibility profiles in a group of Iranian females: prevalence and seasonal variations.

Authors:  Nasrin Shayanfar; Masoud Mohammadpour; Seyede Atefe Hashemi-Moghadam; Mohammad Taghi Haghi Ashtiani; Ali Zare Mirzaie; Nima Rezaei
Journal:  Acta Clin Croat       Date:  2012-12       Impact factor: 0.780

5.  Risk factors for group B streptococcal genitourinary tract colonization in pregnant women.

Authors:  Renee D Stapleton; Jeremy M Kahn; Laura E Evans; Cathy W Critchlow; Carolyn M Gardella
Journal:  Obstet Gynecol       Date:  2005-12       Impact factor: 7.661

6.  Rapid diagnosis of vaginal carriage of group B beta haemolytic streptococcus by an enrichment cum antigen detection test.

Authors:  Anindita Das; Pallab Ray; Meera Sharma; Sarala Gopalan
Journal:  Indian J Med Res       Date:  2003-06       Impact factor: 2.375

Review 7.  Intrapartum antibiotics for known maternal Group B streptococcal colonization.

Authors:  Arne Ohlsson; Vibhuti S Shah
Journal:  Cochrane Database Syst Rev       Date:  2009-07-08

8.  Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC.

Authors:  Stephanie Schrag; Rachel Gorwitz; Kristi Fultz-Butts; Anne Schuchat
Journal:  MMWR Recomm Rep       Date:  2002-08-16

9.  New DNA-based PCR approaches for rapid real-time detection and prevention of group B streptococcal infections in newborns and pregnant women.

Authors:  M G Bergeron; D Ke
Journal:  Expert Rev Mol Med       Date:  2001-11-08       Impact factor: 5.600

10.  Is antenatal group B streptococcal carriage a predictor of adverse obstetric outcome?

Authors:  S M Garland; N Kelly; A M Ugoni
Journal:  Infect Dis Obstet Gynecol       Date:  2000
View more
  5 in total

Review 1.  Group B Streptococcus (Streptococcus agalactiae).

Authors:  Vanessa N Raabe; Andi L Shane
Journal:  Microbiol Spectr       Date:  2019-03

Review 2.  Prevalence of group B streptococcus colonization in Iranian pregnant women: A systematic review and meta-analysis.

Authors:  Mohammad Hossein YektaKooshali; Masoud Hamidi; Seyed Mohammad Taghi Razavi Tousi; Iraj Nikokar
Journal:  Int J Reprod Biomed       Date:  2019-01-28

3.  Clinical Profile and Outcome of Group B Streptococcal Colonization in Mothers and Neonates in Ras Al Khaimah, United Arab Emirates: A Prospective Observational Study.

Authors:  Shatha Taher Salman AlZuheiri; Rajani Dube; Godfred Menezes; Samar Qasem
Journal:  Saudi J Med Med Sci       Date:  2021-09-04

4.  A Multi-Country Cross-Sectional Study of Vaginal Carriage of Group B Streptococci (GBS) and Escherichia coli in Resource-Poor Settings: Prevalences and Risk Factors.

Authors:  Piet Cools; Vicky Jespers; Liselotte Hardy; Tania Crucitti; Sinead Delany-Moretlwe; Mary Mwaura; Gilles F Ndayisaba; Janneke H H M van de Wijgert; Mario Vaneechoutte
Journal:  PLoS One       Date:  2016-01-26       Impact factor: 3.240

5.  Prevalence of Streptococcus agalactiae colonization in pregnant women from the 18th Health Region of Paraná State.

Authors:  Simone Cristina Castanho Sabaini de Melo; Aline Balandis Costa; Flávia Teixeira Ribeiro da Silva; Natália Maria Maciel Guerra Silva; Cristiano Massao Tashima; Rosilene Fressatti Cardoso; Rúbia Andreia F de Pádua; Isolde Previdelli; Maria Dalva de Barros Carvalho; Sandra Marisa Pelloso
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2018-02-15       Impact factor: 1.846

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.